Farm Comunitarios. 2023 Apr 14;15(2):29-40. doi: 10.33620/FC.2173-9218.(2023).15

Strategy to optimize patient safety in the community pharmacy dispensing service. Proposed checklists

Adsuar-Meseguer GM1, Santos-Cruz P2, Pérez-Rodríguez RO3, Granados-Flores J4, Grande de Ulierte E5, López Alarcón MD6, Abrio-Martín C7, Palma-López S8, Luque del Moral R9, Mera Gallego I10
1. Community pharmacist in community pharmacy Quesada Centro. Alicante. 2. Community pharmacist in community pharmacy Leire Azkona Barbed. Bizkaia. 3. Community pharmacist in community pharmacy San Francisco Javier. Arrecife. 4. Community pharmacist in community pharmacy María del Carmen Soto Araneta. Madrid. 5. Community pharmacist in community pharmacy Ulierte. Madrid. 6. Community pharmacist in community pharmacy María Consuelo Cremades Prieto. Murcia. 7. Community pharmacist in community pharmacy Federico Mayo 23. Huelva. 8. Community pharmacist in community pharmacy César Montealegre Gómez. Gáldar, Las Palmas. 9. Community pharmacist in community pharmacy Parque del Este. Valdepeñas, Ciudad Real. 10. Community pharmacist in community pharmacy Eduardo Satué. Maella, Zaragoza.
Adsuar-Meseguer GM, Santos-Cruz P, Pérez-Rodríguez RO, Granados-Flores J, Grande E, López MD, Abrio-Martín C, Palma-López S, Luque R, Mera I. Strategy to optimize patient safety in the community pharmacy dispensing service. Proposed checklists. Farm Comunitarios. 2023 Apr 14;15(2):29-40. doi: 10.33620/FC.2173-9218.(2023).15
Abstract : 

Dispensing is the most requested and important service within the tasks performed by the pharmacist, in his day-to-day work, in the community pharmacy. The aim of dispensing is to guarantee the patient’s access to the medicine in an adequate and controlled manner. During that process, the community pharmacist has the obligation, as a healthcare professional, to actively participate in a committed manner in the detection of possible medication or medication-related errors.

SEFAC´s patient safety group has developed, as the beginning of a series of future projects, checklists and best guidelines for medicines formulated as transdermal patches, modified release forms or orodispersible tablets. 

The aim of this initiative is to minimize as far as possible, by means of a prior interview with the patient and the use of these tools, any errors or problems that might arise with these drugs, thereby ensuring patient safety.

A pilot project is expected to begin throughout 2023 in community pharmacies that collaborate with SEFAC’s patient safety group. Therefore, they will be able to collect and report the results obtained.

Article download link: 

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Manual for authors

Journal Information